grant

Novel 18F and 64Cu labelled targeted nanoparticles for molecular positron emission tomography: A means for early and sensitive detection of thrombosis, inflammation and vulnerable, rupture-prone atherosclerotic plaques [ 2012 - 2014 ]

Also known as: Novel targeted PET nanoparticles for diagnosis of thrombosis, inflammation and prevention of myocardial infarction

Funded by National Health and Medical Research Council
Managed by Baker IDI Heart and Diabetes Institute
Managed by International Diabetes Institute
Provided by   National Health and Medical Research Council

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1029249]

Researchers: Prof Karlheinz Peter (Principal investigator) ,  A/Pr Christoph Hagemeyer ,  A/Pr Uwe Ackermann

Brief description The aim of this project is to develop novel targeted positron emission tomography imaging agents that seek out specific markers for various states of cardiovascular disease. These agents would provide a method for detecting the presence and level of atherosclerosis and thrombotic events. The targeted nanoparticles may provide a unique opportunity to detect very early plaques and the vulnerability of existing plaques.

Funding Amount $AUD 572,931.42

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Help

Related Organisations

Related People

Subjects
Nanotechnology | Nanomedicine | Technology | antibody | atherosclerosis | imaging | inflammation | inflammatory arthritis | molecular imaging | nanotechnology | plaque rupture | positron emission tomography (PET) | thrombosis |
Identifiers
Viewed: [[ro.stat.viewed]]
Saved to MyRDA Save to MyRDA